Lantern Pharma Inc. (LTRN)
NASDAQ: LTRN · Real-Time Price · USD
2.090
-0.150 (-6.70%)
Apr 29, 2026, 11:45 AM EDT - Market open
Lantern Pharma Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2018 |
| Cash & Equivalents | 4.42 | 7.51 | 21.94 | 37.2 | 51.52 | Upgrade
|
| Short-Term Investments | 5.7 | 16.5 | 19.36 | 17.99 | 19.2 | Upgrade
|
| Cash & Short-Term Investments | 10.12 | 24.01 | 41.3 | 55.2 | 70.73 | Upgrade
|
| Cash Growth | -57.86% | -41.86% | -25.17% | -21.96% | 267.80% | Upgrade
|
| Other Receivables | 0.03 | 0.1 | 0.86 | 0.59 | 0.18 | Upgrade
|
| Receivables | 0.03 | 0.1 | 0.86 | 0.59 | 0.18 | Upgrade
|
| Prepaid Expenses | 0.29 | 0.32 | 1.18 | 0.76 | 1.03 | Upgrade
|
| Restricted Cash | - | - | - | 0.54 | - | Upgrade
|
| Other Current Assets | 0.36 | 0.82 | - | 1.63 | 0.78 | Upgrade
|
| Total Current Assets | 10.8 | 25.25 | 43.34 | 58.72 | 72.72 | Upgrade
|
| Property, Plant & Equipment | 0.11 | 0.29 | 0.28 | 0.1 | 0.22 | Upgrade
|
| Long-Term Deferred Charges | 0.09 | - | - | - | - | Upgrade
|
| Other Long-Term Assets | 0.04 | 0.04 | 0.03 | 0.02 | 1.02 | Upgrade
|
| Total Assets | 11.04 | 25.57 | 43.65 | 58.84 | 73.95 | Upgrade
|
| Accounts Payable | 3.06 | 2.42 | 0.94 | 0.93 | 0.68 | Upgrade
|
| Current Portion of Leases | 0.08 | 0.19 | 0.17 | 0.05 | 0.15 | Upgrade
|
| Other Current Liabilities | 1.36 | 1.73 | 1.56 | 1.81 | 1.49 | Upgrade
|
| Total Current Liabilities | 4.5 | 4.33 | 2.68 | 2.8 | 2.33 | Upgrade
|
| Long-Term Leases | - | 0.05 | 0.06 | - | 0.05 | Upgrade
|
| Total Liabilities | 4.5 | 4.38 | 2.74 | 2.8 | 2.38 | Upgrade
|
| Common Stock | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Additional Paid-In Capital | 99.65 | 97.06 | 96.26 | 95.69 | 96.69 | Upgrade
|
| Retained Earnings | -93.15 | -76.03 | -55.24 | -39.28 | -25.02 | Upgrade
|
| Comprehensive Income & Other | 0.03 | 0.15 | -0.11 | -0.37 | -0.09 | Upgrade
|
| Total Common Equity | 6.53 | 21.19 | 40.91 | 56.04 | 71.57 | Upgrade
|
| Shareholders' Equity | 6.53 | 21.19 | 40.91 | 56.04 | 71.57 | Upgrade
|
| Total Liabilities & Equity | 11.04 | 25.57 | 43.65 | 58.84 | 73.95 | Upgrade
|
| Total Debt | 0.08 | 0.24 | 0.23 | 0.05 | 0.2 | Upgrade
|
| Net Cash (Debt) | 10.04 | 23.77 | 41.07 | 55.14 | 70.52 | Upgrade
|
| Net Cash Growth | -57.76% | -42.12% | -25.52% | -21.80% | 268.82% | Upgrade
|
| Net Cash Per Share | 0.92 | 2.21 | 3.79 | 5.08 | 6.47 | Upgrade
|
| Filing Date Shares Outstanding | 11.25 | 10.78 | 10.74 | 10.86 | 10.78 | Upgrade
|
| Total Common Shares Outstanding | 11.25 | 10.78 | 10.72 | 10.86 | 11.09 | Upgrade
|
| Working Capital | 6.3 | 20.92 | 40.66 | 55.92 | 70.39 | Upgrade
|
| Book Value Per Share | 0.58 | 1.96 | 3.82 | 5.16 | 6.45 | Upgrade
|
| Tangible Book Value | 6.53 | 21.19 | 40.91 | 56.04 | 71.57 | Upgrade
|
| Tangible Book Value Per Share | 0.58 | 1.96 | 3.82 | 5.16 | 6.45 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.